Coeptis Therapeutics, Inc. Total Liabilities and Equity
Coeptis Therapeutics, Inc. had Total Liabilities and Equity of $11.26 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2022-11-08
- 2022-09-30: Liabilities and Equity $11.26M.
- 2022-06-30: Liabilities and Equity $6.52M.
- 2022-03-31: Liabilities and Equity $6.75M.
- 2021-12-31: Liabilities and Equity $6.77M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2022-09-30 | $11.26M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $6.52M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $6.75M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $6.77M 10-Q · filed 2022-11-08 | |
| 2021-09-30 | $7.68M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.74M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.12M 10-Q/A · filed 2021-05-18 | |
| 2020-12-31 | $300.48K 10-K · filed 2022-03-11 | $6.36K 10-KT · filed 2021-05-11 |
| 2020-11-30 | $4.94K 10-Q · filed 2021-01-11 | |
| 2020-08-31 | $1.59K 10-Q/A · filed 2020-11-23 | |
| 2020-02-29 | $9.15K 10-Q · filed 2021-01-11 | |
| 2019-12-31 | $20.00K 10-KT · filed 2021-05-11 |